Track Applied Genetic Technologies's receivables ($0) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Applied Genetic Technologies (AGTC) currently reports a receivables of $0 as of September 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Applied Genetic Technologies's receivables history and peer comparisons.
Applied Genetic Technologies's receivables changed from $0 to $0 (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Applied Genetic Technologies reported $0 in receivables as of September 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Applied Genetic Technologies, and consider following AGTC for alerts when major investors trade the stock.
Applied Genetic Technologies is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AGTC with unrelated industries.